Drug Chemical And Associated Technologies Association Inc
Drug Chemical And Associated Technologies Association Inc shows consistent revenue growth and asset accumulation with no reported officer compensation.
EIN: 131980503 · Robbinsville, NJ · Updated: 2026-03-28
Source Check Matrix
What Has Been Verified vs. What Needs Human Review
Identity resolved verified
Drug Chemical And Associated Technologies Association Inc is mapped to EIN 131980503.
IRS BMF exempt record needs review
Open IRS TEOS or BMF source before relying on exemption status.
IRS Pub 78 deductibility needs review
Pub 78 eligibility should be verified in IRS TEOS before money changes hands.
IRS automatic revocation needs review
Check the official auto-revocation bulk source or cached evidence before relying on current exemption.
IRS Form 990 index verified
13 stored filing years available.
Raw 990 source linked
Open ProPublica to verify the raw filing record and PDFs.
Filing depth verified
13 stored filing years available.
State charity registration manual confirmation
Open NJ charity regulator via NASCO; the workflow stops for human confirmation unless a stable source is cached.
Candid / GuideStar profile api pending
Candid API access is not configured; open manually and do not count as verified evidence.
Charity Navigator rating api pending
Charity Navigator API access is not configured; open manually and do not count as verified evidence.
Source and Resolution Links
Finish the Investigation Outside Our Dataset
When the answer lives with the IRS, ProPublica, Candid, Charity Navigator, or the nonprofit itself, NonprofitSpending links out instead of trapping the user on a partial answer.
IRS tax-exempt lookup
Verify exemption status and deductibility directly with the IRS.
IRS bulk evidence downloads
Check Pub 78, automatic revocation, 990-N, and Form 990 bulk evidence sources.
IRS EO BMF extract
Open the official Business Master File extract source for tax-exempt organization records.
ProPublica 990 source
Open the raw filing record and filing PDFs outside NonprofitSpending.
NJ charity regulator via NASCO
Confirm state charity registration or solicitation status where applicable.
Candid profile search
Look for GuideStar/Candid profile details, programs, leadership, and seals.
Charity Navigator search
Check whether another evaluator has ratings or impact context.
Workflow Engine
Queries We Should Resolve, Not Just Answer
Search Console demand points to task completion. Each workflow can run calculations, source checks, external lookups, comparisons, and report/export capture around this nonprofit.
Verify tax status Runnable
Triggered by: 501(c)(3), tax deductible, EIN
IRS status check plus source links
Verify official evidence Runnable
Triggered by: IRS Pub 78, BMF, revocation, 990 index, state registration
Official-source evidence matrix with human stops where a state portal must be checked.
Find source filings Runnable
Triggered by: 990 PDF, annual report, filing record
13 stored filing years plus ProPublica source
Crunch money signals Runnable
Triggered by: program expense ratio, CEO salary, revenue, grants
80% program spend, health grade A
Compare alternatives Runnable
Triggered by: best charities, similar nonprofits, compare
4 peer options surfaced
Resolve leadership and board Runnable
Triggered by: executive team, trustees, officer pay
Use 990 compensation disclosures and external profile links.
Donation decision copilot Runnable
Triggered by: should I donate, give or compare, charity safety
Eligibility, money signals, sources, peer context, and next action.
Grantmaker due diligence Runnable
Triggered by: foundation review, grant risk, grantee capacity
Foundation-style packet across filings, finances, governance, and gaps.
Impact evidence finder Runnable
Triggered by: outcomes, annual report, cost effectiveness
Separate actual impact evidence from raw 990 financial cleanliness.
Room for more funding Runnable
Triggered by: would my donation help, funding gap, marginal impact
Revenue trend, runway, surplus/deficit, and source follow-ups.
Operator transparency diagnostic Runnable
Triggered by: how does my nonprofit look to donors
Profile, filing, impact, and transparency improvements to earn trust.
| Metric | Value |
|---|---|
| Total Revenue | $6.2M |
| Total Expenses | $4.3M |
| Program Spending | 80% |
| CEO/Top Officer Pay | $5 |
| Net Assets | $5.7M |
| Transparency Score | 75/100 |
Search Intent Cockpit
Drug Chemical And Associated Technologies Association Inc Form 990, Revenue, CEO Pay, and IRS Filing Signals
Drug Chemical And Associated Technologies Association Inc is surfaced here as a decision-ready nonprofit financial profile, not just a charity listing. The page consolidates IRS Form 990 revenue, expenses, assets, tax-exempt classification, executive compensation, mission score, red flags, and year-by-year filing history so donors, researchers, journalists, and grant teams can answer the common search questions around Drug Chemical And Associated Technologies Association Inc in one place.
Form 990 Filing Summary
13 filing years are available, with latest revenue of $5.6M and expenses of $4.3M.
Revenue and Expenses
Drug Chemical And Associated Technologies Association Inc reported $5.6M in revenue and $4.3M in expenses, a surplus of $1.3M.
Executive Compensation
Top officer compensation appears as $5 in the stored analysis, with context against revenue and expenses below.
Charity Score and Red Flags
75/100 mission score, 2 red flags, and 4 strengths are shown from structured and AI review.
Is Drug Chemical And Associated Technologies Association Inc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
IRS 990 Data Cockpit
Where the Money Comes From and Where It Goes
Revenue Source Mix
Revenue-source line items are not available on the stored filing yet. Future ingestion now preserves contribution, program-revenue, and investment-income fields when ProPublica provides them.
Expense Deployment
| Program services | $3.4M (80%) |
Across stored filings, Drug Chemical And Associated Technologies Association Inc shows contribution history pending. Next enrichment targets: revenue-source fields, IRS BMF classification.
Decision Cockpit
One-Stop Donor, Research, and Peer Context Hub
| Decision Lens | Signal | What to Inspect Next |
|---|---|---|
| Legitimacy | Some Concerns | Good filing record; 2 red flags identified |
| Mission spend | 80% to programs | Excellent |
| Financial durability | Grade A | 13 stored filing years |
| Peer context | Compare with Dance For The Cure Inc | New Jersey and category context |
Trust Check
Review legitimacy, deductibility, red flags, and filing consistency.
Open charity check →Peer Benchmark
Compare against real state and category peers.
Compare with Dance For The Cure Inc →All New Jersey nonprofits
Local and Sector Spokes
Move into this nonprofit's local market, category, and sector maps.
Robbinsville, NJ nonprofitsFollow the Money
Jump into spending, compensation, rankings, and filing-year evidence.
State spending analysisState compensation analysis
Relevant rankings
Donation Decision Flow
From Trust Check to Better Alternatives
Alternative Shopping
Similar Nonprofits Donors Should Compare
Merck Patient Assistance Program Inc
Rahway, NJ · $1.9B revenue · Score 98/100
Compare side-by-sideMedical Dosimetrist Certification Board
Mount Laurel, NJ · $4.3M revenue · Score 92/100
Compare side-by-sideAtlantic Cape Family Support Organization Inc
Northfield, NJ · $1.1M revenue · Score 92/100
Compare side-by-sideJanet H And C Harry Knowles Foundation Inc
Moorestown, NJ · $29.4M revenue · Score 90/100
Compare side-by-sideNext Best Actions
Keep the Investigation Moving
Research Workflow
Turn this Form 990 profile into a donor-ready report
Request a concise report for Drug Chemical And Associated Technologies Association Inc with revenue, expenses, executive compensation, red flags, peer context, and IRS source links. You can also request CSV exports or watchlist updates for future filings.
Early access request only. Reports and exports are informational and based on public IRS records, not financial or legal advice.
Drug Chemical And Associated Technologies Association Inc directs 80% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Drug Chemical And Associated Technologies Association Inc
Drug Chemical And Associated Technologies Association Inc (EIN: 131980503) is a nonprofit organization based in Robbinsville, NJ. The organization reported total revenue of $6.2M and total assets of $9.8M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Drug Chemical And Associated Technologies Association Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Drug Chemical And Associated Technologies Association Inc is a mid-size nonprofit that has been operating for 63 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 9.5%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $5.6M |
| Total Expenses | $4.3M |
| Surplus / Deficit | +$1.3M |
| Total Assets | $7.5M |
| Total Liabilities | $1.8M |
| Net Assets | $5.7M |
| Operating Margin | 23.5% |
| Debt-to-Asset Ratio | 24.1% |
| Months of Reserves | 21.0 months |
Financial Health Grade: A
In 2023, Drug Chemical And Associated Technologies Association Inc reported a surplus of $1.3M with revenue exceeding expenses, holds 21.0 months of operating reserves (strong position), has a debt-to-asset ratio of 24.1% (moderate leverage).
Financial Trends
Over 13 years of filings (2011–2023), Drug Chemical And Associated Technologies Association Inc's revenue has grown at a compound annual growth rate (CAGR) of 9.5%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +36.1% | +17.5% | +18.0% |
| 2022 | +75.2% | +108.0% | -14.3% |
| 2021 | +12.7% | -22.3% | +16.9% |
| 2020 | -52.1% | -44.1% | +18.7% |
| 2019 | -3.9% | -1.3% | +18.9% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2000 |
| IRS Ruling Date | 1963 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Drug Chemical And Associated Technologies Association Inc with a Mission Score of 75 out of 100 (Good). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 15%
- programs: 80%
- fundraising: 5%
According to IRS 990 filings, Drug Chemical And Associated Technologies Association Inc allocates its expenses as follows: admin: 15%, programs: 80%, fundraising: 5%. With 80% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $1.3M, with revenue exceeding expenses.
- Debt-to-asset ratio: 24.1%.
Executive Compensation Analysis
The organization consistently reports 0% officer compensation across all available filings, which is unusual for an organization of its size with revenues exceeding $5 million. This suggests either a fully volunteer executive leadership or that executive compensation is categorized under other expense lines, which could reduce transparency regarding leadership costs.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Drug Chemical And Associated Technologies Association Inc's IRS 990 filings:
- Consistent 0% officer compensation reported, which may obscure true leadership costs for an organization of this size.
- NTEE code is unknown, which limits understanding of its specific programmatic focus and peer comparison.
Strengths
The following positive indicators were identified for Drug Chemical And Associated Technologies Association Inc:
- Consistent revenue growth, increasing from $2,085,976 in 202010 to $5,604,025 in 202310.
- Strong asset accumulation, growing from $6,336,316 in 202010 to $7,492,601 in 202310.
- Consistently operates with a financial surplus, indicating sound financial management (e.g., $5,604,025 revenue vs. $4,288,341 expenses in 202310).
- Low liabilities relative to assets, with liabilities of $1,803,409 against assets of $7,492,601 in 202310.
Frequently Asked Questions about Drug Chemical And Associated Technologies Association Inc
Is Drug Chemical And Associated Technologies Association Inc a legitimate charity?
Drug Chemical And Associated Technologies Association Inc (EIN: 131980503) is a registered tax-exempt nonprofit based in New Jersey. Our AI analysis gives it a Mission Score of 75/100. It has 13 years of IRS 990 filings on record. Total revenue: $6.2M. 2 red flags identified. 4 strengths noted. Financial health grade: A.
How does Drug Chemical And Associated Technologies Association Inc spend its money?
Drug Chemical And Associated Technologies Association Inc directs 80% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to Drug Chemical And Associated Technologies Association Inc tax-deductible?
Drug Chemical And Associated Technologies Association Inc is registered as a tax-exempt nonprofit (EIN: 131980503). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the Drug Chemical And Associated Technologies Association Inc CEO make?
Drug Chemical And Associated Technologies Association Inc's highest-compensated officer earns $5 annually. The organization reported $6.2M in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of Drug Chemical And Associated Technologies Association Inc's spending goes to programs?
Drug Chemical And Associated Technologies Association Inc directs 80% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
Where is Drug Chemical And Associated Technologies Association Inc located?
Drug Chemical And Associated Technologies Association Inc is headquartered in Robbinsville, New Jersey and files with the IRS under EIN 131980503.
How many years of IRS 990 filings does Drug Chemical And Associated Technologies Association Inc have?
Drug Chemical And Associated Technologies Association Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $6.2M in total revenue.
How does DCAT manage to report 0% officer compensation given its revenue and asset size?
The consistent reporting of 0% officer compensation across all filings is highly unusual for an organization with revenues exceeding $5 million. This could indicate that executive leadership is entirely volunteer-based, or that compensation for key personnel is reported under other expense categories, such as 'salaries and wages' for non-officers, which would obscure the true cost of executive leadership.
What is the breakdown of DCAT's expenses into program, administrative, and fundraising categories?
Based on the available summary data, a precise breakdown is not provided. However, given the consistent surplus (e.g., $5,604,025 revenue vs. $4,288,341 expenses in 202310), the organization appears to manage its overall expenses effectively. A more detailed functional expense statement from the full 990 would be needed to accurately determine the program, administrative, and fundraising ratios.
Has DCAT's financial health improved or declined over the last five years?
DCAT's financial health has significantly improved over the last five years. Revenue has grown from $4,354,304 in 201910 to $5,604,025 in 202310, and assets have increased from $5,339,501 to $7,492,601 over the same period, indicating strong growth and financial stability.
Filing History
IRS 990 filing history for Drug Chemical And Associated Technologies Association Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Drug Chemical And Associated Technologies Association Inc's revenue has grown by 197.1%, moving from $1.9M to $5.6M. Total assets increased by 606% over the same period, from $1.1M to $7.5M. Total functional expenses rose by 118.2%, from $2.0M to $4.3M. In its most recent filing year (2023), Drug Chemical And Associated Technologies Association Inc reported a surplus of $1.3M, with revenue exceeding expenses. The organization holds $1.8M in liabilities against $7.5M in assets (debt-to-asset ratio: 24.1%), resulting in net assets of $5.7M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $5.6M | $4.3M | $7.5M | $1.8M | — | — |
| 2022 | $4.1M | $3.6M | $6.3M | $2.1M | — | — |
| 2021 | $2.4M | $1.8M | $7.4M | $3.1M | — | View 990 |
| 2020 | $2.1M | $2.3M | $6.3M | $3.1M | — | — |
| 2019 | $4.4M | $4.0M | $5.3M | $2.0M | — | View 990 |
| 2018 | $4.5M | $4.1M | $4.5M | $1.6M | — | View 990 |
| 2017 | $4.1M | $3.9M | $3.8M | $1.4M | — | View 990 |
| 2016 | $3.7M | $3.1M | $3.0M | $981K | — | View 990 |
| 2015 | $3.1M | $2.7M | $2.9M | $1.3M | — | View 990 |
| 2014 | $2.8M | $2.4M | $2.4M | $1.2M | — | View 990 |
| 2013 | $2.4M | $2.1M | $2.1M | $1.4M | — | View 990 |
| 2012 | $2.1M | $1.9M | $1.4M | $908K | — | View 990 |
| 2011 | $1.9M | $2.0M | $1.1M | $763K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $5.6M, expenses of $4.3M, and assets of $7.5M (revenue +36.1% year-over-year).
- 2022: Revenue of $4.1M, expenses of $3.6M, and assets of $6.3M (revenue +75.2% year-over-year).
- 2021: Revenue of $2.4M, expenses of $1.8M, and assets of $7.4M (revenue +12.7% year-over-year).
- 2020: Revenue of $2.1M, expenses of $2.3M, and assets of $6.3M (revenue -52.1% year-over-year).
- 2019: Revenue of $4.4M, expenses of $4.0M, and assets of $5.3M (revenue -3.9% year-over-year).
- 2018: Revenue of $4.5M, expenses of $4.1M, and assets of $4.5M (revenue +10.1% year-over-year).
- 2017: Revenue of $4.1M, expenses of $3.9M, and assets of $3.8M (revenue +12.1% year-over-year).
- 2016: Revenue of $3.7M, expenses of $3.1M, and assets of $3.0M (revenue +17.6% year-over-year).
- 2015: Revenue of $3.1M, expenses of $2.7M, and assets of $2.9M (revenue +11.4% year-over-year).
- 2014: Revenue of $2.8M, expenses of $2.4M, and assets of $2.4M (revenue +17.5% year-over-year).
- 2013: Revenue of $2.4M, expenses of $2.1M, and assets of $2.1M (revenue +16.0% year-over-year).
- 2012: Revenue of $2.1M, expenses of $1.9M, and assets of $1.4M (revenue +8.9% year-over-year).
- 2011: Revenue of $1.9M, expenses of $2.0M, and assets of $1.1M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Drug Chemical And Associated Technologies Association Inc:
Data Sources and Methodology
This transparency report for Drug Chemical And Associated Technologies Association Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.